221 related articles for article (PubMed ID: 33926256)
1. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
Rothzerg E; Xu J; Wood D; Kõks S
Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-seq identification of four differentially expressed survival-related genes by a TARGET: Osteosarcoma database analysis.
Feleke M; Feng W; Rothzerg E; Song D; Wei Q; Kõks S; Wood D; Liu Y; Xu J
Exp Biol Med (Maywood); 2022 Jun; 247(11):921-930. PubMed ID: 35285281
[TBL] [Abstract][Full Text] [Related]
3. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
[TBL] [Abstract][Full Text] [Related]
4. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
Liu F; Xing L; Zhang X; Zhang X
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
[TBL] [Abstract][Full Text] [Related]
5. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
6. A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients.
Wu B; Wang Z; Lin N; Yan X; Lv Z; Ying Z; Ye Z
Medicine (Baltimore); 2021 Apr; 100(14):e24118. PubMed ID: 33832059
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel immune-related genes prognostic signature for osteosarcoma.
Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
10. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.
Ho XD; Phung P; Q Le V; H Nguyen V; Reimann E; Prans E; Kõks G; Maasalu K; Le NT; H Trinh L; G Nguyen H; Märtson A; Kõks S
Exp Biol Med (Maywood); 2017 Dec; 242(18):1802-1811. PubMed ID: 29050494
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
Chen J; Guo X; Zeng G; Liu J; Zhao B
Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
13. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
14. A risk assessment model for the prognosis of osteosarcoma utilizing differentially expressed lncRNAs.
Sun K; Zhao J
Mol Med Rep; 2019 Feb; 19(2):1128-1138. PubMed ID: 30569146
[TBL] [Abstract][Full Text] [Related]
15. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
16. Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.
Sun B; Wang F; Li M; Yang M
Med Oncol; 2015 May; 32(5):153. PubMed ID: 25832865
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
[TBL] [Abstract][Full Text] [Related]
18. Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
Zhang Z; Liu C; Liang T; Yu C; Qin Z; Zhou X; Xue J; Zeng H; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2020 Nov; 99(46):e23251. PubMed ID: 33181717
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
20. Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma.
Zhang P; Xu K; Wang J; Zhang J; Quan H
BMC Cancer; 2021 Dec; 21(1):1285. PubMed ID: 34852770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
